AI-driven drug discovery in China reduces screening time

China has introduced an artificial intelligence platform aimed at transforming drug discovery. The system rapidly reviews extensive chemical compound libraries and reduces initial drug screening from months or years to just seconds.

This development reflects a major shift in research timelines. Tasks that once required years can now be completed almost instantly with AI-driven tools. The platform is part of a broader trend toward increased integration of artificial intelligence in biotechnology across the late 2020s.

📰 aipost